EMA To Address Challenges Of Using Organ-On-Chip Models In Drug Development

Microphysiological systems such as organ-on-chip models could not only improve the translational success of drug candidates into the clinic, but also impact the 3Rs in non-clinical safety testing, according to the European Medicines Agency.